Revero
Digital clinic for treating autoimmune and metabolic conditions with personalized medical care and nutrition therapy.
Digital clinic for treating autoimmune and metabolic conditions with personalized medical care and nutrition therapy.
Revero is a pioneering digital clinic in the healthcare industry that offers personalized medical care and nutrition therapy to treat autoimmune and metabolic conditions. With a slogan emphasizing their focus on a root-cause approach, Revero aims to deliver tailored treatments for such chronic conditions. Founded in 2019 and headquartered in the United States, the company recently secured a significant $5.00M Seed Round investment on 03 November 2022. Noteworthy investors participating in this round include CapitalX, Goodwater Capital, Andreessen Horowitz (a16z), and Think + Ventures. Revero’s commitment to addressing underlying factors in autoimmune and metabolic conditions through innovative digital solutions aligns with the growing demand for personalized, remote healthcare. This recent investment signifies a vote of confidence from prominent players in the venture capital space, highlighting the potential for Revero to make a substantial impact on the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $5.00M | 4 |
|
03 Nov 2022 |
| Seed Round | Unknown | 1 |
|
01 Jun 2022 |
| Venture Round | Unknown | 1 |
|
29 Mar 2022 |
No recent news or press coverage available for Revero.
We care about your data, and we'd love to use cookies make your experience better.
